JPM vs NMCO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NMCO exhibits a strong Piotroski F-Score of 7/9, indicating solid short-term financial health, yet it suffers from severe valuation disconnects. While the Price-to-Book ratio of 0.98 suggests the fund is trading near its net asset value, the Graham Number ($2.22) and Intrinsic Value ($0.14) indicate massive overvaluation by traditional equity standards. The dividend yield is attractive at 7.68%, but a payout ratio of 4110% suggests distributions are not supported by earnings. Combined with bearish insider activity and a 0/100 technical trend, the fund appears to be a yield-trap for growth investors but a stable hold for income-focused investors.
Compare Another Pair
Related Comparisons
JPM vs NMCO: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Nuveen Municipal Credit Opportunities Fund (NMCO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.